The Pharmaceutical Price Regulation Scheme (PPRS) came into force in January 2014, and involved the UK industry effectively ... second part of Sarah Rickwood's overview of the UK market will ...
Big questions remain about whether the UK can remain aligned with the European Medicines Agency, without which the pharma industry has warned that the UK could be relegated from its current ...
UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI ...
Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...
The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...
The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the Association of the British Pharmaceutical Industry (ABPI). As one of the ...
Danish company Novo Nordisk's membership in a UK pharmaceutical industry body has been restored after a two-year suspension ...
The UK has announced plans to abolish NHS England and integrate its functions into the central government, marking a ...
Novo Nordisk A/S (NYSE:NVO) returned to full membership of the Association of the British Pharmaceutical Industry (ABPI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results